BSE filing, NSE: GUFICBIO. Summary written from the filing by ALFA Finder's alert engine.
Gufic BioSciences Ltd: key numbers
- Share price
- ₹430.35
- Market cap
- ₹4,316 Cr
- Revenue (annual)
- ₹944.0 Cr
- Net profit (annual)
- ₹64.21 Cr
- P/E (TTM)
- 58.8×Sector 43.0×
- Promoter holding
- 72.50%+0.00% QoQ
- FII holding
- 0.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gufic BioSciences Ltd
All →Gufic BioSciences Board Meeting Date
Gufic Biosciences gives notice of a board meeting on 14 November 2026 to consider unaudited standalone and consolidated quarterly results. The filing carries no financial figures or business decision.
Gufic BioSciences Legal & Regulatory
Gufic Biosciences' tax dispute moved after the ITAT remanded matters to the Assessing Officer. The residual Rs. 11.76 lakh demand will be redetermined in fresh assessment.
- Value
- ₹0.12 Cr
Gufic BioSciences Legal & Regulatory
Gufic Biosciences disclosed an ITAT Mumbai order for AY 2023-24 that set aside the CIT(A) findings and restored the matter to the Assessing Officer. No demand arises from the order, and the tax liability will be determined after fresh assessment.
Gufic BioSciences Business Update
Gufic Biosciences reported a USFDA pre-approval inspection at its Indore facility, concluding October 23, 2026. The inspection produced three Form 483 observations, now being addressed.
Gufic BioSciences Other Announcement
Gufic Biosciences Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Gufic BioSciences Legal & Regulatory
Gufic Biosciences received a favorable appellate order from the Income Tax Commissioner. This order deletes an income tax demand of Rs. 4.33 Crore.
- Value
- ₹4.33 Cr
Other board meeting date announcements
All →Falcon Technoprojects India Board Meeting Date
Falcon Technoprojects will hold a board meeting on 13 November 2026 to consider unaudited half-yearly results. The trading window stays closed until 48 hours after results release.
Modern Diagnostic & Research Centre Board Meeting Date
Modern Diagnostic & Research Centre will hold a board meeting on November 14, 2026. The meeting will consider unaudited standalone half-yearly results to September 2026.
Black Opal Consultants Board Meeting Date
Black Opal Consultants has scheduled a board meeting on 14 November 2026 to approve unaudited half-year financial results for the period ended 30 September 2026. The trading window stays closed until 48 hours after results declaration.
KS Smart Technologies Board Meeting Date
KS Smart Technologies will hold a board meeting on 13 November 2026 to approve unaudited results. The trading window stays closed until results are disseminated.
BharatRohan Airborne Innovations Board Meeting Date
BharatRohan Airborne Innovations gave notice of a board meeting on November 13, 2026, to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The meeting has not yet been held and no results are attached.
Dolphin Medical Services Board Meeting Date
Dolphin Medical Services has notified BSE of a board meeting on 14 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results publication.